The Intravesical Bladder Cancer Therapeutics market was valued at USD 322.23 Million in 2024 and is expected to reach USD 448.85 Million by 2032, growing at a CAGR of 4.23% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.